Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Kidney Donors and Recipients
NCT04346290Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in acute kidney injury (AKI), ischemia-reperfusion injury (IRI), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04346290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04346290.